Vaccine Patent Gives US Government ‘Leverage’ Over Manufacturers

Summary by Cindy Olmstead

The U.S. government is using the leverage of public funding to finance and boost supplies of both Moderna’s and Pfizer’s COVID-19 vaccines, according to Financial Times. The National Institutes of Health holds patents that allow the agency to enforce sharing of intellectual property rights as well as to assess royalties against the vaccine makers but, currently, for some reason the government has not enforced these rights. Should the government decide to exercise its leverage...

Read the Full Article for Free!

You can unsubscribe at any time and I guarantee the privacy of your email. View our privacy policy

Subscribe for FREE to the #1 Natural Health Newsletter or Login for Instant Access

Unlock censored health information that Google doesn't want you to read

Keep your privacy secure — we are one of the few websites that have banned all Google and Facebook scripts to help stop their surveillance capitalism

Get access to all of Dr. Mercola's health articles, E-books and special reports